Thursday, October 4, 2012

Oncogene - Table of Contents alert Volume 31 Issue 40

TABLE OF CONTENTS

Volume 31, Issue 40 (October 2012)

In this issue
Review
Original Articles
Oncogenomics
Corrigendum

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Continuing a tradition of excellence

Oncogene, continues to present the most essential developments in cancer research.

Visit Oncogene’s website now!
 

Review

Top

Diversity within the pRb pathway: is there a code of conduct?

S Munro, S M Carr and N B La Thangue

Oncogene 2012 31: 4343-4352; advance online publication, January 16, 2012; 10.1038/onc.2011.603

Abstract | Full Text

Original Articles

Top

Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells

S Cutrupi, S Reineri, A Panetto, E Grosso, L Caizzi, L Ricci, O Friard, S Agati, M Scatolini, G Chiorino, A E Lykkesfeldt and M De Bortoli

Oncogene 2012 31: 4353-4361; advance online publication, January 16, 2012; 10.1038/onc.2011.627

Abstract | Full Text

Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer

B A Patrick and A K Jaiswal

Oncogene 2012 31: 4362-4371; advance online publication, January 16, 2012; 10.1038/onc.2011.600

Abstract | Full Text

Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR

X Li, Y Lu, K Liang, J-M Hsu, C Albarracin, G B Mills, M-C Hung and Z Fan

Oncogene 2012 31: 4372-4383; advance online publication, January 9, 2012; 10.1038/onc.2011.608

Abstract | Full Text

STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesis

Y Sekine, O Ikeda, A Mizushima, Y Ueno, R Muromoto, A Yoshimura, Y Kanakura, K Oritani and T Matsuda

Oncogene 2012 31: 4384-4396; advance online publication, January 9, 2012; 10.1038/onc.2011.604

Abstract | Full Text

A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers

H Bai, J Inoue, T Kawano and J Inazawa

Oncogene 2012 31: 4397-4408; advance online publication, January 16, 2012; 10.1038/onc.2011.613

Abstract | Full Text

Oncogenomics

Top

Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways

A R Dallosso, B Øster, A Greenhough, K Thorsen, T J Curry, C Owen, A L Hancock, M Szemes, C Paraskeva, M Frank, C L Andersen and K Malik

Oncogene 2012 31: 4409-4419; advance online publication, January 16, 2012; 10.1038/onc.2011.609

Abstract | Full Text

Corrigendum

Top

Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells

S Cutrupi, S Reineri, A Panetto, E Grosso, L Caizzi, L Ricci, O Friard, S Agati, M Scatolini, G Chiorino, A E Lykkesfeldt and M De Bortoli

Oncogene 2012 31: 4420; 10.1038/onc.2012.95

Full Text

Advertisement

Call for papers!

Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function.

Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.

 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: